Top Markets
Coin of the day
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
Rankning i aktier #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
Aktiekurs
$4.51
Marknadsvärde
$540.82M
Förändring (1 dag)
-2.42%
Förändring (1 år)
-43.50%
Land
CN
Handel Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Kategori

Aktiekurshistorik för Nanjing Hicin Pharmaceutical Co., Ltd. (300584)
Högsta slutkurs: $4.90 den 2026-08-01

Lägsta slutkurs: $2.62 den 2017-01-01
Aktiekurshistorik för Nanjing Hicin Pharmaceutical Co., Ltd. från 2017 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -8.43%
2025 143.40%
2024 -11.77%
2023 -29.60%
2022 69.07%
2021 -18.98%
2020 -10.68%
2019 -0.37%
2018 22.24%
2017 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$171.67 -
DE
$165.71 30.94%
DE
$37.61 25.11%
JP
$219.53 25.89%
CH
$21.26 17.56%
IN